Aktivitas Antivirus Polifenol sebagai Profilaksis dan Terapi Potensial dalam Penanganan Covid-19
DOI:
https://doi.org/10.46799/jhs.v3i2.428Keywords:
polyphenol, COVID-19, antiviralAbstract
COVID-19 has caused serious health problems worldwide. Until now, the available therapy hasn’t been fully effective in improving outcomes in COVID-19 patients. Due to the long process of discovering new drugs, the use of available treatment becomes a solution. However, this therapy has several drawbacks, such as decreased effectiveness in mutated viruses and various serious side effects that accompany it. Polyphenols can be considered as adjunctive therapy for COVID-19 because of their rich variety and antiviral activities. This literature review was conducted to summarize the latest evidence regarding the potential antiviral activity of polyphenols as both prophylactic and therapeutic for COVID-19, as well as further discussion on encouragement of polyphenol intake from diets and recommended food examples. Literature sources were taken from journal articles published online from 2017 to 2021. The databases used were MDPI, PubMed, ScienceDirect, Wiley, and Hindawi. Research shows the use of polyphenolic compounds has been approved as a beneficial nutritional or adjunctive therapeutic approach for COVID-19. This is based on the role of polyphenol bioactivity in the pathophysiology of COVID-19, including antioxidant, antiviral, anti-inflammatory, and immunomodulatory effects. Additional studies that specifically examine the administration of polyphenols to pregnant COVID-19 patients and dose safety limits related to interactions with drugs used in the treatment of COVID-19 need to be conducted.
Published
Issue
Section
License
Copyright (c) 2022 Teddy Tjahyanto, Eldy Eldy, Clarissa Felicia, Karmenia Jessica Karmenia Jessica , Olivia Larissa
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under aCreative Commons Attribution-ShareAlike 4.0 International (CC-BY-SA). that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
